Neuropathological studies revealed that the 6A2B2 anti-HERV-W Env antibody reacts with an antigen that is strongly expressed by glial cells in MS brain lesions, but not in normal control brain tissue [18,21,22]. Here, ERVW-1 is linked to myeloid sarcoma.